Proteus Digital Health said today that the first cancer patients were treated using its digital oncology therapy, which combines oral chemotherapy with an ingestible sensor.
Patients with stage 3 and 4 colorectal cancer at the University of Minnesota Health and Fairview Health Services were treated with digital capecitabine. The Redwood City, Calif.-based company plans to use its sensor-drug combination to record and share data such as the time and dose of chemotherapy that a patient ingests.
Get the full story at our sister site, Drug Delivery Business News.
The post Proteus debuts digital cancer drug appeared first on MassDevice.
from MassDevice http://bit.ly/2TTOvuh
Cap comentari:
Publica un comentari a l'entrada